{"id":107765,"date":"2026-06-05T09:39:15","date_gmt":"2026-06-05T04:09:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=107765"},"modified":"2026-06-05T09:39:15","modified_gmt":"2026-06-05T04:09:15","slug":"genxai-analytics-ipo-gmp-day-1-june-5-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/genxai-analytics-ipo-gmp-day-1-june-5-2026\/","title":{"rendered":"Genxai Analytics IPO GMP Day 1 on 5 June 2026: Rs 8 Grey Market Premium Signals 6.9% Expected Listing Gain on NSE SME"},"content":{"rendered":"
<\/div>\n

Genxai Analytics IPO GMP Day 1 (June 5): Rs 8\/share. Expected listing Rs 124 (+6.9%). Price Rs 110-116. Issue size Rs 54.84 Cr. Close Jun 9. Listing Jun 12 NSE SME.<\/em><\/p>\n

The Genxai Analytics IPO GMP is grabbing the attention of IPO investors on 5 June 2026, as the Day 1 of the public issue shows Day 1 activity building as retail investors begin applying.<\/p>\n

Genxai Analytics Limited, incorporated in 2007 and headquartered in India, is a technology-driven enterprise performance and analytics solutions company. The Genxai Analytics IPO is backed by a business that offers AI-enabled workflow and analytics platforms including enterprise planning (EPM), data engineering, analytics, cloud solutions, application development, and Generative AI solutions. The company integrates data across finance, sales, operations, customer management, and human resources into unified systems that enable data-driven decision-making. As of March 2026, the company had 362 permanent employees, with the majority in technology and delivery roles.<\/p>\n

The grey market premium (GMP) for Genxai Analytics IPO GMP is currently Rs 8 per share, indicating an expected listing price of approximately Rs 124 against the upper price band of Rs 110 to Rs 116 per share per share, implying a potential listing gain of approximately 6.9%.<\/p>\n

Investors must note that grey market premium is an unofficial, unregulated indicator that is not governed by SEBI. GMP fluctuates daily based on investor sentiment, subscription data, and broader market conditions. The Genxai Analytics IPO GMP grey market premium should be used as one data point. Investors tracking the Genxai Analytics IPO GMP among many in the investment decision process, not as the primary factor. Investors should review the full prospectus before applying for the Genxai Analytics IPO GMP. This does not constitute investment advice.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n